Clinical Trials Browser

Phase 3 × Thyroid Cancer, Papillary × Endocrine × Clear all

NCT03690388 2025-09-25

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Phase 3 Active not recruiting

187 enrolled 13 charts 1 FDA

EndocrineHead & Neck

Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT06791005 2025-01-24

A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.

Phase 3 Recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT00795782 2016-04-15

Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma

Phase 3 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis, Thyroid Neoplasms

NCT00295763 2015-03-18

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Phase 3 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular